Uses 　　　　　　　4-Oxo-1,4-dihydroquinoline-3-carboxylic acid is intermediate of ivacaftor

                                             Ivacaftor is used to treat cystic fibrosis in adults and children who are at least 6 months old and weigh at least 11 pounds (5 kilograms). Ivacaftor is for use only in patients with a specific gene mutation related to cystic fibrosis. Before you take ivacaftor, you may need a medical test to make sure you have this gene mutation.

1.  what is its main application?

It is  intermediate of  ivacaftor

2.  how many years we produced it, and what is its capactity

It produced since 2018。 And capacity is 20mt annually.

3. what is plant location and nearest port

It located in a chemical zone Fujian province., and nearest port is Xiamen port

4.  if doc. Support and audit available?

Yes, VQ and allied tech. package is available for serious client.  Audit could be accepted for clients having business more than 1 year.

5.  what other products are producing or plan to produce in this plant 

Advanced pharmaceutical intermediates，e.g. intermediats of Pramipexole，Rivastigmine，Ramatroban，ivacaftor，Olaparib etc.